Roly Foulkes

Company: Revolo Biotherapeutics

Job title: CSO

Seminars:

A Revolutionary Approach to Resetting the Immune System for Long-Term Disease Remission 3:30 pm

• Revolo Biotherapeutics is advancing revolutionary approaches to reset the immune system and achieve long term disease remission • ‘1805 is a protein that in a phase 2 clinical trial, showed disease remission in Rheumatoid Arthritis after a single dose and has applicability in a wide range of autoimmune diseases • ‘1104 is a peptide…Read more

day: Day One